Option Care Health Inc

OPCH is exhibiting a Stage 4 decline with a bearish medium-term bias and price consolidating around the 9/20/50 EMAs in an overbought range. Immediate sell timing is limited, so execution should be deferred, trimming into strength on rallies toward resistance zones aligned with EMAs.

• ↑Q2 revenue rose 2% YoY to $1.4B (7% QoQ) with high single-digit organic growth
• ↑Operating cash flow $184M and free cash flow $256M fund growth initiatives
• ↓Profitability pressured by negative profitability factors and margin stress